Quarterly report pursuant to Section 13 or 15(d)

Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.2
Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in-Captial
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 43,069 $ 61,087,082 $ (52,993,325) $ 8,136,826
Balance (in Shares) at Dec. 31, 2019 43,069,418      
Stock-based compensation 882,645 882,645
Equity modification expense 802,400 802,400
Exercise of employee stock options $ 72 42,154 42,226
Exercise of employee stock options (in Shares) 71,981      
Net loss (4,217,563) (4,217,563)
Balance at Mar. 31, 2020 $ 43,141 62,814,281 (57,210,888) 5,646,534
Balance (in Shares) at Mar. 31, 2020 43,141,399      
Stock-based compensation 653,127 653,127
Sale of common stock, net $ 2,350 4,302,765 4,305,115
Sale of common stock, net (in Shares) 2,350,067      
Equity modification expense 998,643 998,643
Exercise of employee stock options $ 134 190,197 190,331
Exercise of employee stock options (in Shares) 133,860      
Exercise of warrants $ 20 44,980 45,000
Exercise of warrants (in Shares) 20,000      
Net loss (4,102,529) (4,102,529)
Balance at Jun. 30, 2020 $ 45,645 69,003,993 (61,313,417) 7,736,221
Balance (in Shares) at Jun. 30, 2020 45,645,326      
Stock-based compensation 370,685 370,685
Reduction of ATM offering costs 3,237 3,237
Sale of common stock in CMPO, net $ 12,300 13,643,231   13,655,531
Sale of common stock in CMPO, net (in Shares) 12,300,000      
Equity modification expense 489,645 489,645
Exercise of employee stock options $ 18 19,810   19,828
Exercise of employee stock options (in Shares) 18,083      
Net loss (3,236,919) (3,236,919)
Balance at Sep. 30, 2020 $ 57,963 83,530,601 (64,550,336) 19,038,229
Balance (in Shares) at Sep. 30, 2020 57,963,409      
Balance at Dec. 31, 2020 $ 61,118 87,684,323 (69,258,286) 18,487,155
Balance (in Shares) at Dec. 31, 2020 61,117,524      
Stock-based compensation 320,444 320,444
Exercise of employee stock options $ 624 958,223 958,847
Exercise of employee stock options (in Shares) 623,901      
Exercise of warrants $ 46 67,490 67,536
Exercise of warrants (in Shares) 46,900      
Net loss (4,038,344) (4,038,344)
Balance at Mar. 31, 2021 $ 61,788 89,030,480 (73,296,630) 15,795,638
Balance (in Shares) at Mar. 31, 2021 61,788,325      
Stock-based compensation 957,558 957,558
Sale of common stock, net $ 481 621,341 621,822
Sale of common stock, net (in Shares) 481,102      
Net loss (5,223,365) (5,223,365)
Balance at Jun. 30, 2021 $ 62,269 90,609,379 (78,519,995) 12,151,653
Balance (in Shares) at Jun. 30, 2021 62,269,427      
Stock-based compensation 681,835 681,835
Issuance of common stock for ESPP plan $ 18 16,796 16,814
Issuance of common stock for ESPP plan (in Shares) 17,662      
Sale of common stock, net $ 1,177 2,261,787 2,262,964
Sale of common stock, net (in Shares) 1,176,774      
Exercise of employee stock options $ 160 157,140 157,300
Exercise of employee stock options (in Shares) 160,000      
Exercise of warrants $ 1,404 2,020,536 2,021,940
Exercise of warrants (in Shares) 1,404,125      
Net loss     (3,421,758) (3,421,758)
Balance at Sep. 30, 2021 $ 65,028 $ 95,747,473 $ (81,941,753) $ 13,870,748
Balance (in Shares) at Sep. 30, 2021 65,027,988